Prostaglandin E2 Activates mTORC1 Pathway Through an EP Receptor/PKA-Mediated Mechanism

被引：0
|
作者：
Chang, H. [1 ]
Eibl, G. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA
来源：
PANCREAS | 2014年 / 43卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1347 / 1347
页数：1
相关论文
共 50 条
  • [1] Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA and EP1/calcium-mediated mechanisms in human pancreatic carcinoma cells
    Chang, Hui-Hua
    Young, Steven
    Sinnett-Smith, James
    Chou, Caroline Ei Ne
    Hines, Oscar Joe
    Rozengurt, Enrique
    Eibl, Guido
    CANCER RESEARCH, 2015, 75
  • [2] Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1
    Chang, Hui-Hua
    Young, Steven H.
    Sinnett-Smith, James
    Chou, Caroline Ei Ne
    Moro, Aune
    Hertzer, Kathleen M.
    Hines, Oscar Joe
    Rozengurt, Enrique
    Eibl, Guido
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2015, 309 (10): : C639 - C649
  • [3] Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism
    Schmidt, Andrea
    Sinnett-Smith, James
    Young, Steven
    Chang, Hui-Hua
    Hines, O. Joe
    Dawson, David W.
    Rozengurt, Enrique
    Eibl, Guido
    SURGERY, 2017, 161 (06) : 1570 - 1578
  • [4] The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAPM/PKA/mTORC1/rpS6 Pathway
    Xu, Hu
    Fang, Bingying
    Bao, Chengzhen
    Mao, Xiuhui
    Zhu, Chunhua
    Ye, Lan
    Liu, Qian
    Li, Yaqing
    Du, Chunxiu
    Qi, Hang
    Zhang, Xiaoyan
    Guan, Youfei
    CELLS, 2022, 11 (17)
  • [5] PROSTAGLANDIN E2 ENHANCES LIVER REGENERATION THROUGH CAMP/PKA-MEDIATED REGULATION OF NUCLEAR β-CATENIN ACCUMULATION
    Goessling, Wolfram
    North, Trista E.
    Schmitt, Sabine
    Lord, Allegra M.
    Lee, Sang
    Puder, Mark
    Moon, Randall T.
    Daley, George
    Zon, Leonard I.
    HEPATOLOGY, 2008, 48 (04) : 340A - 340A
  • [6] Prostaglandin E2 Suppression Of Myofibroblast Differentiation Is Mediated By The PKA Signaling Pathway
    Garrison, G.
    Huang, S. K.
    Wettlaufer, S. H.
    Okunishi, K.
    Peters-Golden, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [7] Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway
    Sawasdikosol, Sansana
    Pyarajan, Saiju
    Alzabin, Saba
    Matejovic, Gabriel
    Burakoff, Steven J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (48) : 34693 - 34699
  • [8] Angiotensin II activates mTORC1 pathway in the kidneys through a pressor-independent mechanism
    Shimada, Satoshi
    Yang, Chun
    Kumar, Vikash
    Stumph, Megan
    Kurth, Theresa
    Mattson, David
    Cowley, Allen, Jr.
    FASEB JOURNAL, 2020, 34
  • [9] The inhibitory effect of bupivacaine on prostaglandin E2 (EP1) receptor functioning:: Mechanism of action
    Hönemann, CW
    Heyse, TJ
    Möllhoff, T
    Hahnenkamp, K
    Berning, S
    Hinder, F
    Linck, B
    Schmitz, W
    van Aken, H
    ANESTHESIA AND ANALGESIA, 2001, 93 (03): : 628 - 634
  • [10] Anticancer effect and mechanism of prostaglandin E2 receptor EP4 antagonist
    Nonomura, Kazuhiko
    Miyama, Katsuyoshi
    Kanazawa, Kiyoshi
    Okumura, Takako
    Okumura, Yoshiyuki
    Oshima, Masanobu
    Takahashi, Satoru
    Take, Yukinori
    CANCER RESEARCH, 2012, 72
12345